Synopsys (SNPS) Receiving Somewhat Positive Press Coverage, Report Shows

News coverage about Synopsys (NASDAQ:SNPS) has been trending somewhat positive on Wednesday, Accern Sentiment Analysis reports. Accern identifies positive and negative news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Synopsys earned a news sentiment score of 0.11 on Accern’s scale. Accern also assigned headlines about the semiconductor company an impact score of 45.596661480842 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Shares of Synopsys (SNPS) opened at $91.32 on Wednesday. Synopsys has a 12 month low of $62.12 and a 12 month high of $94.80. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.04. The firm has a market capitalization of $13,574.59, a price-to-earnings ratio of 107.44, a P/E/G ratio of 4.07 and a beta of 1.01.

Synopsys (NASDAQ:SNPS) last issued its quarterly earnings data on Wednesday, November 29th. The semiconductor company reported $0.69 EPS for the quarter, beating analysts’ consensus estimates of $0.57 by $0.12. The firm had revenue of $696.60 million for the quarter, compared to analyst estimates of $650.72 million. Synopsys had a return on equity of 5.78% and a net margin of 5.01%. The company’s revenue for the quarter was up 9.9% on a year-over-year basis. During the same period in the prior year, the firm posted $0.77 EPS. equities analysts expect that Synopsys will post 2.24 earnings per share for the current year.

A number of research analysts recently issued reports on the company. Zacks Investment Research raised Synopsys from a “hold” rating to a “buy” rating and set a $91.00 price target for the company in a report on Tuesday, October 3rd. Needham & Company LLC boosted their price objective on Synopsys from $83.00 to $100.00 and gave the stock a “buy” rating in a report on Friday, December 1st. Royal Bank of Canada reissued a “buy” rating and set a $120.00 price objective on shares of Synopsys in a report on Thursday, November 30th. DA Davidson reissued a “buy” rating and set a $105.00 price objective (up from $91.00) on shares of Synopsys in a report on Tuesday, November 28th. Finally, BidaskClub upgraded Synopsys from a “hold” rating to a “buy” rating in a research report on Tuesday, January 23rd. Two research analysts have rated the stock with a sell rating, one has given a hold rating and eight have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $96.89.

In related news, CEO Chi-Foon Chan sold 3,750 shares of the firm’s stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $89.78, for a total value of $336,675.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Steven Walske sold 4,545 shares of the stock in a transaction dated Wednesday, January 17th. The shares were sold at an average price of $90.12, for a total value of $409,595.40. Following the completion of the transaction, the director now owns 14,988 shares of the company’s stock, valued at $1,350,718.56. The disclosure for this sale can be found here. Over the last three months, insiders have sold 65,442 shares of company stock worth $5,779,693. 1.82% of the stock is currently owned by insiders.

ILLEGAL ACTIVITY WARNING: This article was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this article on another site, it was illegally copied and reposted in violation of U.S. & international copyright & trademark laws. The original version of this article can be viewed at https://www.dispatchtribunal.com/2018/01/31/synopsys-snps-getting-somewhat-positive-news-coverage-accern-reports.html.

Synopsys Company Profile

Synopsys, Inc provides software, intellectual property (IP) and services. The Company supplies the electronic design automation (EDA) software that engineers use to design and test integrated circuits, also known as chips. It also offers IP products, which are pre-designed circuits that engineers use as components of larger chip designs rather than designing those circuits themselves.

Insider Buying and Selling by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply